Merck (MRK) shares traded close to flat today, holding steady as investors weigh recent performance and updates from the pharmaceutical sector. Despite minimal movement, the company’s multi-month returns and fundamentals are still catching attention.

See our latest analysis for Merck.

Merck’s stock has seen some renewed momentum lately, posting a 7.7% share price gain over the past week and nearly 10% over the last month, despite a year-to-date dip. While its one-year total shareholder return barely budged, the recent surge suggests that investors are once again warming up to Merck’s long-term prospects compared to earlier in 2024.

Curious to see what else is catching investor interest in healthcare? Discover more companies making…